img

Global Transplantation of Multipotent Hematopoietic Stem Cells Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Transplantation of Multipotent Hematopoietic Stem Cells Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
Transplantation of Multipotent Hematopoietic Stem Cells report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transplantation of Multipotent Hematopoietic Stem Cells market is projected to reach US$ 2627.2 million in 2033, increasing from US$ 1348 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2033. Demand from Leukemia and Lymphoproliferative Disorders are the major drivers for the industry.
The Transplantation of Hematopoietic Stem Cells market is primarily driven by its potential to provide curative treatments for various hematological disorders, including leukemia, lymphoma, and certain genetic diseases. Hematopoietic stem cell transplantation (HSCT) involves replacing damaged or malfunctioning bone marrow with healthy stem cells to restore normal blood cell production. The increasing prevalence of hematological diseases, coupled with advancements in transplantation techniques, contributes to market growth. Moreover, the demonstrated benefits of HSCT in achieving long-term remission, improving overall survival rates, and offering a potential cure for patients with limited treatment options further propel adoption. However, challenges include finding suitable donors, addressing potential graft-versus-host disease and other complications, and managing post-transplant care. Navigating patient-donor matching, ensuring graft compatibility, and providing comprehensive patient support are ongoing concerns. The market's success relies on continuous research in transplantation science, collaborations between medical institutions and stem cell banks, and comprehensive education on the benefits and potential challenges of hematopoietic stem cell transplantation while addressing the evolving challenges associated with donor availability and patient outcomes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Transplantation of Multipotent Hematopoietic Stem Cells market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis
Segment by Type
Stem Cells Storage
Stem Cells Consumables

Segment by Application


Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transplantation of Multipotent Hematopoietic Stem Cells market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Transplantation of Multipotent Hematopoietic Stem Cells introduction, etc. Transplantation of Multipotent Hematopoietic Stem Cells Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Transplantation of Multipotent Hematopoietic Stem Cells market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Transplantation of Multipotent Hematopoietic Stem Cells
1.1 Transplantation of Multipotent Hematopoietic Stem Cells Market Overview
1.1.1 Transplantation of Multipotent Hematopoietic Stem Cells Product Scope
1.1.2 Transplantation of Multipotent Hematopoietic Stem Cells Market Status and Outlook
1.2 Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Region (2018-2033)
1.4 Global Transplantation of Multipotent Hematopoietic Stem Cells Historic Market Size by Region (2018-2023)
1.5 Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033)
1.6.1 North America Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033)
1.6.2 Europe Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033)
1.6.3 Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033)
1.6.4 Latin America Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033)
1.6.5 Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033)
2 Transplantation of Multipotent Hematopoietic Stem Cells Market by Type
2.1 Introduction
2.1.1 Stem Cells Storage
2.1.2 Stem Cells Consumables
2.2 Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Transplantation of Multipotent Hematopoietic Stem Cells Historic Market Size by Type (2018-2023)
2.2.2 Global Transplantation of Multipotent Hematopoietic Stem Cells Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Transplantation of Multipotent Hematopoietic Stem Cells Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Transplantation of Multipotent Hematopoietic Stem Cells Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Transplantation of Multipotent Hematopoietic Stem Cells Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Transplantation of Multipotent Hematopoietic Stem Cells Revenue Breakdown by Type (2018-2033)
3 Transplantation of Multipotent Hematopoietic Stem Cells Market Overview by Application
3.1 Introduction
3.1.1 Leukemia
3.1.2 Lymphoproliferative Disorders
3.1.3 Solid Tumors
3.1.4 Non-Malignant Disorders
3.2 Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Transplantation of Multipotent Hematopoietic Stem Cells Historic Market Size by Application (2018-2023)
3.2.2 Global Transplantation of Multipotent Hematopoietic Stem Cells Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Transplantation of Multipotent Hematopoietic Stem Cells Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Transplantation of Multipotent Hematopoietic Stem Cells Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Transplantation of Multipotent Hematopoietic Stem Cells Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Transplantation of Multipotent Hematopoietic Stem Cells Revenue Breakdown by Application (2018-2033)
4 Transplantation of Multipotent Hematopoietic Stem Cells Competition Analysis by Players
4.1 Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transplantation of Multipotent Hematopoietic Stem Cells as of 2022)
4.3 Date of Key Players Enter into Transplantation of Multipotent Hematopoietic Stem Cells Market
4.4 Global Top Players Transplantation of Multipotent Hematopoietic Stem Cells Headquarters and Area Served
4.5 Key Players Transplantation of Multipotent Hematopoietic Stem Cells Product Solution and Service
4.6 Competitive Status
4.6.1 Transplantation of Multipotent Hematopoietic Stem Cells Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 CBR Systems
5.1.1 CBR Systems Profile
5.1.2 CBR Systems Main Business
5.1.3 CBR Systems Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
5.1.4 CBR Systems Transplantation of Multipotent Hematopoietic Stem Cells Revenue (US$ Million) & (2018-2023)
5.1.5 CBR Systems Recent Developments
5.2 China Cord Blood Corporation
5.2.1 China Cord Blood Corporation Profile
5.2.2 China Cord Blood Corporation Main Business
5.2.3 China Cord Blood Corporation Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
5.2.4 China Cord Blood Corporation Transplantation of Multipotent Hematopoietic Stem Cells Revenue (US$ Million) & (2018-2023)
5.2.5 China Cord Blood Corporation Recent Developments
5.3 ViaCord
5.3.1 ViaCord Profile
5.3.2 ViaCord Main Business
5.3.3 ViaCord Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
5.3.4 ViaCord Transplantation of Multipotent Hematopoietic Stem Cells Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Transplantation of Multipotent Hematopoietic Stem Cells Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 STEMCELL Technologies
5.5.1 STEMCELL Technologies Profile
5.5.2 STEMCELL Technologies Main Business
5.5.3 STEMCELL Technologies Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
5.5.4 STEMCELL Technologies Transplantation of Multipotent Hematopoietic Stem Cells Revenue (US$ Million) & (2018-2023)
5.5.5 STEMCELL Technologies Recent Developments
5.6 Vcanbio
5.6.1 Vcanbio Profile
5.6.2 Vcanbio Main Business
5.6.3 Vcanbio Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
5.6.4 Vcanbio Transplantation of Multipotent Hematopoietic Stem Cells Revenue (US$ Million) & (2018-2023)
5.6.5 Vcanbio Recent Developments
5.7 Merck Millipore
5.7.1 Merck Millipore Profile
5.7.2 Merck Millipore Main Business
5.7.3 Merck Millipore Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
5.7.4 Merck Millipore Transplantation of Multipotent Hematopoietic Stem Cells Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Millipore Recent Developments
5.8 Lonza Group
5.8.1 Lonza Group Profile
5.8.2 Lonza Group Main Business
5.8.3 Lonza Group Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
5.8.4 Lonza Group Transplantation of Multipotent Hematopoietic Stem Cells Revenue (US$ Million) & (2018-2023)
5.8.5 Lonza Group Recent Developments
5.9 CellGenix Technologie Transfer
5.9.1 CellGenix Technologie Transfer Profile
5.9.2 CellGenix Technologie Transfer Main Business
5.9.3 CellGenix Technologie Transfer Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
5.9.4 CellGenix Technologie Transfer Transplantation of Multipotent Hematopoietic Stem Cells Revenue (US$ Million) & (2018-2023)
5.9.5 CellGenix Technologie Transfer Recent Developments
5.10 ThermoGenesis
5.10.1 ThermoGenesis Profile
5.10.2 ThermoGenesis Main Business
5.10.3 ThermoGenesis Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
5.10.4 ThermoGenesis Transplantation of Multipotent Hematopoietic Stem Cells Revenue (US$ Million) & (2018-2023)
5.10.5 ThermoGenesis Recent Developments
6 North America
6.1 North America Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Transplantation of Multipotent Hematopoietic Stem Cells Market Dynamics
11.1 Transplantation of Multipotent Hematopoietic Stem Cells Industry Trends
11.2 Transplantation of Multipotent Hematopoietic Stem Cells Market Drivers
11.3 Transplantation of Multipotent Hematopoietic Stem Cells Market Challenges
11.4 Transplantation of Multipotent Hematopoietic Stem Cells Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Transplantation of Multipotent Hematopoietic Stem Cells Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size Share by Region (2018-2023)
Table 4. Global Transplantation of Multipotent Hematopoietic Stem Cells Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Transplantation of Multipotent Hematopoietic Stem Cells Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Type (2018-2023)
Table 9. Global Transplantation of Multipotent Hematopoietic Stem Cells Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Type (2024-2033)
Table 11. North America Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Application (2018-2023)
Table 24. Global Transplantation of Multipotent Hematopoietic Stem Cells Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Application (2024-2033)
Table 26. North America Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Transplantation of Multipotent Hematopoietic Stem Cells Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transplantation of Multipotent Hematopoietic Stem Cells as of 2022)
Table 39. Date of Key Players Enter into Transplantation of Multipotent Hematopoietic Stem Cells Market
Table 40. Global Transplantation of Multipotent Hematopoietic Stem Cells Key Players Headquarters and Area Served
Table 41. Transplantation of Multipotent Hematopoietic Stem Cells Product Solution and Service
Table 42. Global Transplantation of Multipotent Hematopoietic Stem Cells Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. CBR Systems Basic Information List
Table 45. CBR Systems Description and Business Overview
Table 46. CBR Systems Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
Table 47. Revenue (US$ Million) in Transplantation of Multipotent Hematopoietic Stem Cells Business of CBR Systems (2018-2023)
Table 48. CBR Systems Recent Developments
Table 49. China Cord Blood Corporation Basic Information List
Table 50. China Cord Blood Corporation Description and Business Overview
Table 51. China Cord Blood Corporation Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
Table 52. Revenue (US$ Million) in Transplantation of Multipotent Hematopoietic Stem Cells Business of China Cord Blood Corporation (2018-2023)
Table 53. China Cord Blood Corporation Recent Developments
Table 54. ViaCord Basic Information List
Table 55. ViaCord Description and Business Overview
Table 56. ViaCord Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
Table 57. Revenue (US$ Million) in Transplantation of Multipotent Hematopoietic Stem Cells Business of ViaCord (2018-2023)
Table 58. ViaCord Recent Developments
Table 59. Thermo Fisher Scientific Basic Information List
Table 60. Thermo Fisher Scientific Description and Business Overview
Table 61. Thermo Fisher Scientific Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
Table 62. Revenue (US$ Million) in Transplantation of Multipotent Hematopoietic Stem Cells Business of Thermo Fisher Scientific (2018-2023)
Table 63. Thermo Fisher Scientific Recent Developments
Table 64. STEMCELL Technologies Basic Information List
Table 65. STEMCELL Technologies Description and Business Overview
Table 66. STEMCELL Technologies Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
Table 67. Revenue (US$ Million) in Transplantation of Multipotent Hematopoietic Stem Cells Business of STEMCELL Technologies (2018-2023)
Table 68. STEMCELL Technologies Recent Developments
Table 69. Vcanbio Basic Information List
Table 70. Vcanbio Description and Business Overview
Table 71. Vcanbio Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
Table 72. Revenue (US$ Million) in Transplantation of Multipotent Hematopoietic Stem Cells Business of Vcanbio (2018-2023)
Table 73. Vcanbio Recent Developments
Table 74. Merck Millipore Basic Information List
Table 75. Merck Millipore Description and Business Overview
Table 76. Merck Millipore Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
Table 77. Revenue (US$ Million) in Transplantation of Multipotent Hematopoietic Stem Cells Business of Merck Millipore (2018-2023)
Table 78. Merck Millipore Recent Developments
Table 79. Lonza Group Basic Information List
Table 80. Lonza Group Description and Business Overview
Table 81. Lonza Group Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
Table 82. Revenue (US$ Million) in Transplantation of Multipotent Hematopoietic Stem Cells Business of Lonza Group (2018-2023)
Table 83. Lonza Group Recent Developments
Table 84. CellGenix Technologie Transfer Basic Information List
Table 85. CellGenix Technologie Transfer Description and Business Overview
Table 86. CellGenix Technologie Transfer Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
Table 87. Revenue (US$ Million) in Transplantation of Multipotent Hematopoietic Stem Cells Business of CellGenix Technologie Transfer (2018-2023)
Table 88. CellGenix Technologie Transfer Recent Developments
Table 89. ThermoGenesis Basic Information List
Table 90. ThermoGenesis Description and Business Overview
Table 91. ThermoGenesis Transplantation of Multipotent Hematopoietic Stem Cells Products, Services and Solutions
Table 92. Revenue (US$ Million) in Transplantation of Multipotent Hematopoietic Stem Cells Business of ThermoGenesis (2018-2023)
Table 93. ThermoGenesis Recent Developments
Table 94. North America Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 95. North America Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2024-2033) & (US$ Million)
Table 96. Europe Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 97. Europe Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2024-2033) & (US$ Million)
Table 98. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 99. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Region (2018-2023) & (US$ Million)
Table 100. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Region (2024-2033) & (US$ Million)
Table 101. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Market Share by Region (2018-2023)
Table 102. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Market Share by Region (2024-2033)
Table 103. Latin America Transplantation of Multipotent Hematopoietic Stem Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 104. Latin America Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 105. Latin America Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2024-2033) & (US$ Million)
Table 106. Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 107. Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 108. Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2024-2033) & (US$ Million)
Table 109. Transplantation of Multipotent Hematopoietic Stem Cells Market Trends
Table 110. Transplantation of Multipotent Hematopoietic Stem Cells Market Drivers
Table 111. Transplantation of Multipotent Hematopoietic Stem Cells Market Challenges
Table 112. Transplantation of Multipotent Hematopoietic Stem Cells Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Transplantation of Multipotent Hematopoietic Stem Cells Market Share by Regions: 2022 VS 2033
Figure 4. Global Transplantation of Multipotent Hematopoietic Stem Cells Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Transplantation of Multipotent Hematopoietic Stem Cells Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Transplantation of Multipotent Hematopoietic Stem Cells Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Transplantation of Multipotent Hematopoietic Stem Cells Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Stem Cells Storage
Figure 11. Global Stem Cells Storage Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Stem Cells Consumables
Figure 13. Global Stem Cells Consumables Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size Share by Type: 2022 & 2033
Figure 15. North America Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Type (2018-2033)
Figure 16. Europe Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Type (2018-2033)
Figure 20. Leukemia Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Lymphoproliferative Disorders Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Solid Tumors Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Non-Malignant Disorders Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size Share by Application: 2022 & 2033
Figure 25. North America Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Application (2018-2033)
Figure 26. Europe Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Application (2018-2033)
Figure 27. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Application (2018-2033)
Figure 28. Latin America Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Application (2018-2033)
Figure 29. Middle East and Africa Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Application (2018-2033)
Figure 30. Transplantation of Multipotent Hematopoietic Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 31. Global Top 5 and Top 10 Players Transplantation of Multipotent Hematopoietic Stem Cells Market Share in 2022
Figure 32. North America Transplantation of Multipotent Hematopoietic Stem Cells Market Share by Country (2018-2033)
Figure 33. United States Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 34. Canada Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 35. Germany Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 36. France Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 37. U.K. Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 38. Italy Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 39. Russia Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 40. Nordic Countries Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 41. Asia-Pacific Transplantation of Multipotent Hematopoietic Stem Cells Market Share by Region (2018-2033)
Figure 42. China Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 43. Japan Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 44. South Korea Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 46. India Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 47. Australia Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 48. Latin America Transplantation of Multipotent Hematopoietic Stem Cells Market Share by Country (2018-2033)
Figure 49. Mexico Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 50. Brazil Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 51. Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells Market Share by Country (2018-2033)
Figure 52. Turkey Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 54. UAE Transplantation of Multipotent Hematopoietic Stem Cells Market Size (2018-2033) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report